Medical Condition News

RSS

Lowering door-to-balloon times helps benefit STEMI patients, study finds

While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or percutaneous coronary intervention, is the most common emergency treatment for STEMI.

30 Apr 2013

Molecular pathway that helps form new arteries after heart attacks uncovered

Scientific collaborators from Yale School of Medicine and University College London have uncovered the molecular pathway by which new arteries may form after heart attacks, strokes and other acute illnesses bypassing arteries that are blocked.

30 Apr 2013

Scientists discover novel drug molecule that reduces swelling, inflammation in arthritic joints

A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis.

30 Apr 2013

UCLA study shows individuals with BDD have global bad wiring in their brains

Body dysmorphic disorder is a disabling but often misunderstood psychiatric condition in which people perceive themselves to be disfigured and ugly, even though they look normal to others. New research at UCLA shows that these individuals have abnormalities in the underlying connections in their brains.

30 Apr 2013

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Acute pancreatitis is an inflammation of the pancreas which leads to leakage of pancreatic enzymes. Apart from certain drugs such as GLP-1 based therapies, the most common causes of pancreatitis are Gallstones and Alcohol use.

30 Apr 2013

Academy asks public to wear orange in support of skin cancer awareness on Melanoma Monday

The American Academy of Dermatology aims to paint the nation orange this May by asking the public to wear orange in support of skin cancer awareness on Melanoma Monday, May 6.

30 Apr 2013

Sufferers of gout and elevated uric acid levels have significantly increased death risks

A new study led by researchers at the Graduate Entry Medical School (GEMS), University of Limerick (UL) has found that people suffering from gout and elevated serum uric acid have significantly increased risks of death.

30 Apr 2013

Golfers may be at risk for skin cancer, say LUHS dermatologists

Golfers may have more to worry about than just their short game or backswing this summer. They also may be at risk for skin cancer, according to dermatologists at Loyola University Health System.

30 Apr 2013

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

A debilitating mental illness, schizophrenia can be difficult to diagnose. Because physiological evidence confirming the disease can only be gathered from the brain during an autopsy, mental health professionals have had to rely on a battery of psychological evaluations to diagnose their patients.

30 Apr 2013

Kcentra gets FDA approval for adults with acute major bleeding

The U.S. Food and Drug Administration today approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist anticoagulation in adults with acute major bleeding.

30 Apr 2013

Neuroscientists identify cellular change in the brain that accompanies obesity

A team of American and Italian neuroscientists has identified a cellular change in the brain that accompanies obesity. The findings could explain the body's tendency to maintain undesirable weight levels, rather than an ideal weight, and identify possible targets for pharmacological efforts to address obesity.

30 Apr 2013

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.

30 Apr 2013

Study: Green tea extract with polyethylene glycol could help control body weight gain

Evidence has shown that green tea extract may be an effective herbal remedy useful for weight control and helping to regulate glucose in type 2 diabetes.

30 Apr 2013

Gene study may uncover regulatory network that influences development of cardiovascular disease

University of North Carolina researchers have discovered that disrupting a gene that acts as a regulatory switch to turn on other genes can keep blood vessels from forming and developing properly.

30 Apr 2013

Naturopathic lifestyle counselling helps reduce risk of cardiovascular disease

Counselling and treatment with naturopathic care as well as enhanced usual care reduced the prevalence of metabolic syndrome, a risk factor for heart disease, by 17% over a year for participants in a randomized controlled trial published in CMAJ.

30 Apr 2013

New research shows more than a third of stroke patients don't get to hospital by ambulance

More than a third of stroke patients don't get to the hospital by ambulance, even though that's the fastest way to get there, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

30 Apr 2013

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.

From Pfizer, Inc. 30 Apr 2013

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.

29 Apr 2013

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema, is now available in the United Kingdom.

29 Apr 2013

CVRx enrolls first patient in Barostim HOPE4HF clinical trial

CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is evaluating the effectiveness and safety of CVRx's Barostim neo in heart failure patients.

29 Apr 2013

Medical Condition News

Lowering door-to-balloon times helps benefit STEMI patients, study finds

Molecular pathway that helps form new arteries after heart attacks uncovered

Scientists discover novel drug molecule that reduces swelling, inflammation in arthritic joints

UCLA study shows individuals with BDD have global bad wiring in their brains

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Academy asks public to wear orange in support of skin cancer awareness on Melanoma Monday

Sufferers of gout and elevated uric acid levels have significantly increased death risks

Golfers may be at risk for skin cancer, say LUHS dermatologists

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

Kcentra gets FDA approval for adults with acute major bleeding

Neuroscientists identify cellular change in the brain that accompanies obesity

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Study: Green tea extract with polyethylene glycol could help control body weight gain

Gene study may uncover regulatory network that influences development of cardiovascular disease

Naturopathic lifestyle counselling helps reduce risk of cardiovascular disease

New research shows more than a third of stroke patients don't get to hospital by ambulance

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

CVRx enrolls first patient in Barostim HOPE4HF clinical trial

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News